What does this research mean for the field?

Early initiation of long-acting injectable antipsychotics reduces hospitalization burden in first-episode schizophrenia patients. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

The aim is to assess how latency to initiating long-acting injectable antipsychotics affects hospitalization in first-episode schizophrenia.

February 16, 2026

Latency to Long-Acting Injectable Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia.

Key Points

The aim is to assess how latency to initiating long-acting injectable antipsychotics affects hospitalization in first-episode schizophrenia.
Analyzed patient data on LAI initiation times and subsequent hospitalization rates.
Evaluated treatment adherence in relation to timing of LAI use.
Compared outcomes of early versus delayed LAI initiation.
Earlier initiation of long-acting injectable antipsychotics associated with significantly lower hospitalization rates.
Delayed initiation linked to slightly better treatment adherence, but with increased hospitalization burden.

Abstract

Conclusion: Although delayed initiation was linked to better treatment adherence, early LAI use reduced hospitalization burden, supporting guidelines advocating earlier LAI treatment in schizophrenia.

Ask AI

Mark Helpful

Bookmark

Relay